CDEK
← All organizations

Genelabs Technologies

For profitContributed to NME

Also known as: World Gen | WORLD GEN

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 1, 1998

First marketed drug

Jan 5, 2001

Last known activity

Jul 1, 2003

Acquired by GlaxoSmithKline on Jan 1, 2008

Timeline

1980s

  1. Jan 1, 1983

    Genelabs Technologies— Founded

2000s

  1. Jan 5, 2001

    cefaclor— Marketing Organization

  2. Jan 1, 2008

    GlaxoSmithKline— Acquired By

Drugs by trial phase (3 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (4)

Details

Founded
Redwood City, CA, US Jan 1, 1983
Last known activity
Jul 1, 2003